Neuberger Berman Group
AXSM icon

Neuberger Berman Group’s Axsome Therapeutics AXSM Stock Holding History

Neuberger Berman Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3M Buy
156,523
+95,764
+158% +$20.8M 0.03% 568
2026
Q1 		$10.3M Sell
60,759
-8,724
-13% -$1.51M 0.01% 809
2025
Q4 		$12.7M Sell
69,483
-21,695
-24% -$3.03M 0.01% 756
2025
Q3 		$11.1M Buy
91,178
+20,546
+29% +$2.31M 0.01% 780
2025
Q2 		$7.37M Buy
+70,632
New +$7.48M 0.01% 861
2024
Q4 		– Sell
-80,014
Closed -$7.19M – 1935
2024
Q3 		$7.19M Buy
80,014
+5,247
+7% +$458K 0.01% 860
2024
Q2 		$6.02M Sell
74,767
-16,889
-18% -$1.25M ﹤0.01% 866
2024
Q1 		$7.31M Buy
91,656
+3,026
+3% +$254K 0.01% 849
2023
Q4 		$7.05M Buy
+88,630
New +$5.93M ﹤0.01% 994
2020
Q4 		– Sell
-34,500
Closed -$2.46M – 1677
2020
Q3 		$2.46M Buy
34,500
+7,000
+25% +$545K ﹤0.01% 1026
2020
Q2 		$2.26M Buy
27,500
+11,000
+67% +$847K ﹤0.01% 984
2020
Q1 		$971K Sell
16,500
-3,500
-18% -$285K ﹤0.01% 1103
2019
Q4 		$2.07M Sell
20,000
-12,900
-39% -$521K ﹤0.01% 1023
2019
Q3 		$666K Buy
32,900
+3,500
+12% +$89.9K ﹤0.01% 1222
2019
Q2 		$757K Sell
29,400
-12,600
-30% -$253K ﹤0.01% 1207
2019
Q1 		$598K Buy
+42,000
New +$390K ﹤0.01% 1214

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Neuberger Berman Group's AXSM Position: Q2 2026 in Review

Neuberger Berman Group increased its Axsome Therapeutics (AXSM) stake by 158% in Q2 2026, buying an estimated $20.8M and bringing the position to 156,523 shares worth $38.3M. The position accounts for 0.03% of the portfolio, ranked #568.

Neuberger Berman Group first reported a position in AXSM in Q1 2019 and has held it in 16 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Neuberger Berman Group held 156,523 shares of Axsome Therapeutics worth $38.3M as of Q2 2026.
  • Neuberger Berman Group bought 95,764 Axsome Therapeutics shares in Q2 2026, an estimated $20.8M.
  • Axsome Therapeutics made up 0.03% of Neuberger Berman Group's portfolio in Q2 2026, its #568 holding.
  • Neuberger Berman Group first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 16 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.